SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001411690-22-000006
Filing Date
2022-03-01
Accepted
2022-03-01 16:04:47
Documents
16
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bngo-20220301.htm   iXBRL 8-K 37531
2 EX-99.1 bngopressrelease-20211231.htm EX-99.1 159644
7 image.jpg GRAPHIC 4793
8 image_0.jpg GRAPHIC 382434
  Complete submission text file 0001411690-22-000006.txt   930039

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bngo-20220301.xsd EX-101.SCH 2307
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bngo-20220301_def.xml EX-101.DEF 16041
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bngo-20220301_lab.xml EX-101.LAB 30841
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bngo-20220301_pre.xml EX-101.PRE 16728
10 EXTRACTED XBRL INSTANCE DOCUMENT bngo-20220301_htm.xml XML 14217
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 22697885
SIC: 3826 Laboratory Analytical Instruments